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abstract: Objectives: Transfusions are a common medical intervention. Discussion of the benefits, risks and 
alternatives with the patient is mandated by many legislations prior to planned transfusions. At the Sultan Qaboos 
University Hospital (SQUH), Muscat, Oman, a written transfusion consent policy was introduced in March 2014. 
This was the first time such a policy was implemented in Oman. This study therefore aimed to assess adherence to 
this policy among different specialties within SQUH. Methods: The medical records of patients who underwent 
elective transfusions between June and August 2014 were reviewed to assess the presence of transfusion consent 
forms. If present, the consent forms were examined for completeness of patient, physician and witness information. 
Results: In total, the records of 446 transfused patients (299 adult and 147 paediatric patients) were assessed. 
Haematology patients accounted for 50% of adult patients and 71% of paediatric patients. Consent was obtained for 
75% of adult and 91% of paediatric patients. The highest adherence rate was observed among adult and paediatric 
haematology specialists (95% and 97%, respectively). Consent forms were correctly filled out with all details 
provided for 51% and 52% of adult and paediatric patients, respectively. Among inadequately completed forms, 
the most common error was a lack of witness details (20–25%). Conclusion: In most cases, the pre-transfusion 
consent policy was successfully adhered to at SQUH. However, further work is required to ensure full compliance 
with the consent procedure within different specialties. Implementation of transfusion consent in other hospitals 
in the country is recommended.
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الدم  اإجراء عملية نقل  الدم تدخاًل طبيًا �صائعًا. مناق�صة املنافع واملخاطر والبدائل مع املري�ض قبل  اأهداف: تعترب عملية نقل  امللخ�ص: 
�صيا�صة  اإدخال  �صلطنة عمان، مت  )SQUH(، م�صقط،  ال�صلطان قابو�ض  الت�رضيعات، يف م�صت�صفى جامعة  العديد من  اإجراء فر�صته  ب�صفته 
املوافقة اخلطيِّة امل�صبقة لعملية نقل الدم يف مار�ض 2014م. كانت هذه هي املرة االأوىل التي تنفذ فيها هذه ال�صيا�صة يف عمان. تهدف هذه 
الدرا�صة اإىل تقييم االلتزام بهذه ال�صيا�صة بني التخ�ص�صات املختلفة يف SQUH. منهجية: متت مراجعة ال�صجالت الطبية للمر�صى الذين 
خ�صعوا لعمليات نقل الدم بني يونيو واأغ�صط�ض عام 2014م لتقييم وجود ا�صتمارات املوافقة، مت فح�ض مناذج املوافقة اإن وجدت �صمن 
معلومات املري�ض، الطبيب وال�صهود. نتائج: يف املجموع، مت تقييم �صجالت 446 مري�صا مت نقل الدم اإليهم )299 بالغ و 147 طفل مري�ض(. 
�صكل امل�صابون باأمرا�ض الدم %50 من املر�صى البالغني و %71 من االأطفال. ومت احل�صول على املوافقة لدى %75 من البالغني و 91% 
من االأطفال املر�صى. لوحظ اأن اأعلى ن�صبة لاللتزام ب�صيا�صة اقتناء املوافقة اخلطيِّة قبل عملية نقل الدم كانت بني اأطباء ق�صم الدم للبالغني 
واالأطفال )%95 و %97 على التوايل(. مت تعبئة ا�صتمارات املوافقة ب�صكل �صحيح بجميع التفا�صيل اخلا�صة بـ %51 و %52 من املر�صى 
البالغني واالأطفال على التوايل. من بني النماذج غري املكتملة كان اخلطاأ االأكرث �صيوعًا عدم وجود تفا�صيل ال�صهود )%25-20(. خامتة: يف 
معظم احلاالت، مت االلتزام ب�صيا�صة موافقة ما قبل نقل الدم بنجاح يف SQUH. ومع ذلك، هناك حاجة اإىل مزيد من العمل ل�صمان االلتزام 
الكامل الإجراءات املوافقة امل�صبقة يف خمتلف التخ�ص�صات، ويو�صى بتنفيذ موافقة عملية نقل الدم يف امل�صت�صفيات االأخرى يف البلد.
كلمات مفتاحية: نقل الدم؛ موافقة م�صبقة؛ االمتثال لل�صيا�صات؛ املراجعة ال�رضيرية؛ عمان.
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Advances in Knowledge 
- This study assessed adherence to transfusion consent policy at the Sultan Qaboos University Hospital, the first centre in Oman to 
implement transfusion consent.
Application to Patient Care 
- Written patient consent and discussion of the risks and benefits of transfusion procedures has become increasingly important. 
- The authors of this study advocate wide implementation of transfusion consent in all hospitals in Oman as an integral part of 
patient autonomy. 
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Blood transfusion is a frequent inter-vention which should only be performed to avoid significant morbidity or mortality 
if not given.1 Although blood transfusions are safe 
in comparison to other medical and surgical 
interventions, they nevertheless carry certain risks, 
such as transfusion reactions, alloimmunisation, 
immunomodulation and transfusion-transmitted 
infections.2 Patient consent for blood transfusions 
is a topic that has long stimulated debate among 
healthcare practitioners.2,3 Previously, verbal informed 
consent for a blood transfusion was often considered 
sufficient to authorise the procedure; however, with 
the recognition of transfusion hazards, effective and 
documented counselling of risks and benefits has 
become increasingly important.2,3 As such, patients 
receiving blood transfusions should be provided 
with sufficient information regarding the purpose, 
anticipated benefits, alternatives to the blood trans- 
fusion and their expected outcome without the 
transfusion. Additionally, patients should be made 
aware of frequent and significant transfusion-related 
risks.4 Following this, the caregiver must obtain 
patient consent which must be given voluntarily by 
the patient or a parent or legally appointed guardian, 
when applicable.5,6 Ideally, there should be witnessed 
verification of the patient’s signature.6 
Worldwide variation exists regarding the practice 
of obtaining informed consent from patients prior 
to a blood transfusion. While in many countries 
this practice is not routine, it is mandated in others, 
with the prescribing physician being responsible for 
obtaining consent.6–9 Concerns regarding transfusion-
transmitted infections have resulted in legislation 
in some jurisdictions in the USA which requires 
physicians to obtain written informed consent for 
blood transfusions.10 In the UK, there is a widespread 
recommendation that patients must be informed 
about blood transfusions, although this is not routinely 
practiced.9,11 In Canada, requirements to inform 
patients about blood transfusions are stated in Justice 
Krever’s recommendation for the blood system.8,12 This 
recommendation mandates that patients should be 
informed about the benefits, risks and alternatives to 
allogeneic blood transfusions and that this discussion 
needs to be documented in patients’ medical records.12
Transfusion consent in Oman was first introduced 
at the Sultan Qaboos University Hospital (SQUH), 
Muscat, Oman, in March 2014. The transfusion 
consent policy mandates that all patients—or their 
eligible guardians in paediatric cases or with adult 
patients unable to give informed consent—provide 
pre-transfusion written consent by signing a consent 
form which confirms that they have been given 
information on transfusion of blood and/or blood 
components by a qualified physician. The physician 
must explain the risks and benefits of and alternatives 
to blood transfusion prior to obtaining the consent. 
The consent process should be witnessed by another 
healthcare provider, such as a physician or a nurse, 
and all information, including any refusal of blood 
and blood components, should be documented in 
the patient’s electronic medical records. For non-
chronically transfused patients, consent is renewed 
upon each patient admission. Furthermore, the policy 
requires that consent be obtained prior to a planned 
elective transfusion during the same admission 
period. Patients on long-term blood support (e.g. 
patients with underlying haemoglobinopathies and 
those undergoing chemotherapy) should provide 
consent annually with an option to withdraw their 
consent at any time during that period. In emergency 
situations where the patient or their guardian is unable 
or unavailable to provide consent, pre-transfusion 
consent requirements are waived; in these cases, 
patients or guardians are retroactively informed about 
the requirements of and reasons for performing the 
blood transfusion.
Prior to implementation of the policy, hospital-
wide educational sessions were initiated to raise 
awareness of the new policy, procedures for trans-
fusion consent, patient rights, the elements of consent, 
how consent is given and the validity of consent and 
its documentation. A pocket guide was made available 
and distributed to all nurses and physicians in the 
hospital to aid implementation of the policy. This study 
therefore aimed to assess adherence to the transfusion 
consent policy among different specialties at SQUH.
Methods
This cross-sectional retrospective quantitative study 
included all chronically and non-chronically trans-
fused patients who underwent elective transfusions 
between June and August 2014. The medical records 
of these patients were examined for the presence of 
a transfusion consent form. In addition, the forms 
were examined for completeness of patient, physician 
and witness information and medical records were 
examined for any documentation of refusal of 
consent. Blood bank records of all blood components 
transfused during June–August 2014 were reviewed 
for information regarding issued blood components 
to ensure the inclusion of all patients during the 
study period.
Data collected were entered into Microsoft Excel, 
Version 2010 (Microsoft Corp., Redmond, Washington, 
USA) and analysed using the Statistical Package for 
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the Social Sciences (SPSS), Version 22.0 (IBM Corp., 
Chicago, Illinois, USA). Descriptive statistics were 
used to summarise the results and associations were 
tested using Fisher’s exact test. A P value of <0.0500 
was considered statistically significant. 
Ethical approval for this study was obtained 
from the Medical Research & Ethics Committee of 
the College of Medicine & Health Sciences at Sultan 
Qaboos University (MREC #961).
Results
During the study period, 446 transfused patients from 
different specialties were assessed, including 299 adult 
and 147 paediatric patients. Of these, 49% of the adult 
and 70% of the paediatric patients were on chronic 
transfusion support. Haematology patients accounted 
for 50% of adult patients, while the remaining adults 
were admitted by general medicine, surgery or 
obstetrics and gynaecology teams. The majority of 
transfused patients in the paediatric age group were 
haematology patients (71%), with the rest admitted 
under the care of general paediatric, paediatric surgery 
and neonatology teams [Table 1]. 
Consent was obtained for a total of 359 subjects 
(75% of adult and 91% of paediatric patients) [Table 2]. 
Paediatric and adult haematology specialists demon-
strated the greatest adherence to the policy (97% 
and 95%, respectively). In contrast, only 55% of 
transfused patients under the care of adult non-
haematology services had documented transfusion 
consent forms. However, paediatric non-haematology 
specialists showed a higher adherence rate (76%). 
Upon assessment of the completeness of the consent 
forms among paediatric patients, 52% were filled out 
adequately with all of the required information. Adult 
and paediatric haematology specialists had correctly 
filled out consent forms in 77% and 66% of cases, 
respectively [Table 2].
A statistically significant difference was found 
between haematology and non-haematological special-
ists with regards to the completeness of consent forms 
for both adults and paediatric patients (P = 0.0001 
each). In both patient groups, the most common error 
was a lack of witness name and/or signature (20–25%). 
In paediatric consent forms, 26% lacked the physicians’ 
name in comparison to 13% of adult consent forms 
[Figure 1]. The names and signatures of the patients’ 
parents or guardians were present in 95% and 97% of 
paediatric consents, respectively.
Discussion
Over recent years, patients have become more involv-
ed in their medical and surgical treatments. Despite 
Table 1: Characteristics of patients who underwent elective 
transfusions at the Sultan Qaboos University Hospital, 
Muscat, Oman, by admitting department* (N = 446)
Patient group n (%)
Adults (n = 299)
Haematology 149 (50)
Non-haematology 150 (50)
     Surgery 54 (36)
     Gynaecology and obstetrics 50 (33)
     Medicine 48 (32)
Paediatric (n = 147)
Haematology 105 (71)
Non-haematology 42 (29)
     Neonatology 22 (52)
     General paediatrics 11 (26)
     Paediatric surgery 9 (21)
*Assessed for the presence of transfusion consent in their clinical records.
Table 2: Transfusion consent and degree of completeness 
of consent forms among patients who underwent elective 
transfusions at the Sultan Qaboos University Hospital, 
Muscat, Oman, by admitting department (N = 446)
Patient group n (%)
Consent taken Completeness 
of form
Adults (n = 299) 225 152
Haematology 142 (95) 114 (77)
Non-haematology 83 (55) 38 (25)
Paediatrics (n = 147) 134 76
Haematology 102 (97) 69 (66)
Non-haematology 32 (76) 7 (17)
 
Figure 1: Chart showing the degree of completeness of 
various components of consent forms among patients 
who underwent elective transfusions at the Sultan 
Qaboos University Hospital, Muscat, Oman (N = 359).
MRN = medical record number.
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this, inconsistencies have been reported in the 
practice of obtaining consent for blood transfusions. 
Transfusion consent has been mandated in some 
countries, while obtaining specific consent for a 
transfusion remains a novel concept in others. 
Furumaki et al. found that patients who were provided 
with information were more likely to have a better 
understanding of the risks and benefits of transfusion.13 
However, research indicates that only 50–60% of 
transfusion patients recall having a discussion with 
their physicians or giving their consent for a blood 
transfusion; this indicates that current processes to 
aid informed patient decision-making fall short.7,9,14 
Court et al. reported limited patient awareness of a 
transfusion having occurred at all, indicating a lack 
of communication between healthcare providers and 
their patients.7 In Oman, written patient consent 
for blood transfusions was not in practice at any 
government hospital before 2014 and SQUH was the 
first hospital in the country to implement a transfusion 
consent policy. 
The findings of the current study show excellent 
adherence to the consent policy in the SQUH 
haematology specialty for both adult and paediatric 
cases. Further effort is hence required to enhance 
adherence in other specialties at SQUH. One 
explanation for the lower adherence to consent policy 
observed among non-haematology specialties in the 
current study could be a failure in documenting consent 
in medical records. Similar audits at other institutions 
have shown a lack of documentation of transfusion 
consent, raising the need for efforts to improve the 
documentation process.15 At SQUH, the preliminary 
results of the current survey were presented to heads 
of departments and members of the blood transfusion 
committee; action plans were put in place for the re-
education of staff hospital-wide. In addition, a quarterly 
nursing-specific course on transfusion practices was 
initiated, with emphasis on aspects related to 
transfusion reactions and the consent process. An 
introductory session of transfusion policies in the 
hospital was prepared specifically for new physicians 
and residents. Moreover, re-assessment of policy 
adherence via a second survey is planned following the 
implementation of these remedial actions. 
In addition, the findings of the present study have 
highlighted issues relating to the proper completion of 
transfusion consent forms. Lack of witness information 
was a common issue and the importance of this 
element should be emphasised in future policies. This 
finding may potentially be due to language or cultural 
barriers. It is important that the witness understands 
the language in which the consent explanation is given 
in order to be able to document consent properly. 
In many healthcare settings, the witness is usually 
the nurse responsible for administering the blood 
components; at SQUH, the feasibility of this approach 
is limited as nurses do not always speak the same 
language as their patients. This problem is applicable 
to other aspects of the consent process as well and 
raises the need for specific hospital policies to address 
this issue.
Recently, the distribution of transfusion informa-
tion pamphlets has been recommended as a means of 
improving information delivery, since patient rarely 
report being informed of the specifics of the transfusion 
or its benefits/risks.6,7 Nevertheless, it is important to 
note that these pamphlets cannot be given to illiterate 
patients or those with sight disabilities; furthermore, 
Court et al. found that although patients reportedly 
valued pamphlets as a source of information, over 
half of the patients who remembered discussing blood 
transfusions with their caregivers felt that the best 
source of information was a physician.7 Educational 
pamphlets were recently designed for distribution 
at SQUH in order to aid physicians during informed 
consent discussions. However, it was emphasised to the 
healthcare providers that written information should 
not replace verbal discussion with the patient during 
the consent process. Implementation of the consent 
process in other hospitals in Oman is advocated by the 
researchers as a vital step towards patient autonomy 
and to establish a method for the on-going monitoring 
of transfusion processes. 
There is a lack of published data assessing the 
amount of information given to patients before 
obtaining transfusion consent or patients’ levels of 
understanding of the information provided during the 
consent process.7 Informed consent for transfusion 
presumes that the patient has been given sufficient 
information, was able to comprehend the information 
provided and was given the opportunity to ask 
questions before making their decision. Furthermore, 
patients need to agree to undergo the intervention 
based on the information provided. In the current 
study, the degree of information provided or the 
patients’ comprehension of the provided information 
was not assessed. Previous studies have shown that 
there is variability in the amount of information 
delivered to patients during the informed consent 
discussion.16,17 The current study lays the groundwork 
for further assessment of these aspects in the future.
Although blood transfusion consent policies 
have been applied in nearby countries as a result of 
accreditation requirements, to the best of the authors’ 
knowledge, this study is the first from Oman to assess 
the degree of adherence to an informed consent 
policy. However, a few limitations of the study should 
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be considered. First, the generalisability of this study 
may be limited since the subjects consisted of a 
patient cohort from a single institution. However, 
transfusion consent in Oman was only implemented 
at SQUH at the time of writing. The extent to which 
these findings can be replicated in a wider patient 
and physician population remains to be determined 
pending implementation of the policy at other 
hospitals. Second, the policy was introduced at SQUH 
relatively recently and it will thus understandably 
take further education of physicians and patients 
before a better level of adherence can be achieved. 
Third, the study assessed neither the degree of patient 
comprehension of information provided during the 
consent process, nor the details of what the physicians 
discussed with their patients. Further studies on these 
aspects are recommended.
Conclusion
This study describes the first experience of transfusion 
consent policy application in Oman and found high 
adherence among haematology specialties. Further 
effort is required to expand adherence in other medical 
and surgical specialties. Greater efforts should be made 
to provide information to patients about the benefits 
and risks of and alternatives to blood transfusion. 
Distribution of information pamphlets at SQUH is 
in process and will be followed by a second survey to 
assess the effectiveness of this in policy adherence. 
However, the adequacy of communication delivered 
and patient understanding during the consent 
process has yet to be assessed. The authors advocate 
implementation of the consent process in other 
hospitals in Oman as a vital step towards increased 
patient autonomy and to establish a method for on-
going monitoring of the transfusion process.
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